Recent Posts
- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Archives
IWD2023 interview series, Feature Five: Gertrude Biomedical CEO/Managing Director, Tara Karnezis
Tara Karnezis is the Chief Executive Officer and Managing Director of IR Department’s client, Gertrude Biomedical. Tara oversees Gertrude’s development of small molecule medicines that target cancer growth and spread.
We were grateful to her for giving us some time as part of our International Women's Day interview series, to discuss her perspective on this year’s theme, “Embracing Equity”.
IWD2023 interview series, Feature Four: HaemaLogiX Chair/CEO, Bryce Carmine
Bryce Carmine is the Chairman and Chief Executive Officer with IR Department’s client, HaemaLogiX, a private Australian biotech company developing immune-based treatments for multiple myeloma.
We were grateful for Bryce giving us some time, as part of our International Women's Day series, to share some insights and perspective on this year’s theme, “Embracing Equity”.
IWD2023 interview series, Feature Three: Pureprofile’s COO/CFO, Melinda Sheppard
Melinda Sheppard is the Chief Operating Officer and Chief Financial Officer with IR Department client, Pureprofile Limited (ASX: PPL). Together with CEO Martin Filz, Melinda has been instrumental in the turnaround of the Pureprofile business over the past few years.
We were grateful that she could spend some time with us as part of our International Women's Day series, to share some insights from her career and her perspective on this year’s theme, “Embracing Equity”.
IWD2023 – Mary Harney talks about the importance of mentoring and optimism
As part of International Women’s Day 2023, IR Department sat down with leaders across a range of industries to discuss their unique perspectives on the theme of “embracing equity”.
In this interview, we speak with Mary Harney (pictured), who is Non-Executive Director for our client, Race Oncology (ASX: RAC), and also Chair of both Oncology One and Microbio.
Mary has had a fascinating career history across health and agricultural sectors. A thoughtful, analytical and persuasive leader, Mary’s positive influence has seen prominent businesses and cultures transformed. A constant throughout her career has been the wealth of opportunity created for both women and men through mentoring and career championship.
IWD2023 interview series, Feature One: Servatus' Non-Executive Director Eilis Quinn
Eilis Quinn is General Manager, Australia and New Zealand at Jazz Pharmaceuticals and is also Non-Executive Director with IR Department client, Servatus.
Recently Eilis took some time out to chat with our Communications Director, Cherie Hartley about International Women’s Day, her experiences and perspectives around this year’s theme, “Embracing Equity”.
- 1
